These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 6428407)

  • 1. N-acetyl-5-methoxy kynurenamine, a brain metabolite of melatonin, is a potent inhibitor of prostaglandin biosynthesis.
    Kelly RW; Amato F; Seamark RF
    Biochem Biophys Res Commun; 1984 May; 121(1):372-9. PubMed ID: 6428407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of diazepam binding by tryptophan derivatives including melatonin and its brain metabolite N-acetyl-5-methoxy kynurenamine.
    Marangos PJ; Patel J; Hirata F; Sondhein D; Paul SM; Skolnick P; Goodwin FK
    Life Sci; 1981 Jul; 29(3):259-67. PubMed ID: 7289793
    [No Abstract]   [Full Text] [Related]  

  • 3. Anti-inflammatory actions of melatonin and its metabolites, N1-acetyl-N2-formyl-5-methoxykynuramine (AFMK) and N1-acetyl-5-methoxykynuramine (AMK), in macrophages.
    Mayo JC; Sainz RM; Tan DX; Hardeland R; Leon J; Rodriguez C; Reiter RJ
    J Neuroimmunol; 2005 Aug; 165(1-2):139-49. PubMed ID: 15975667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of neuronal nitric oxide synthase activity by N1-acetyl-5-methoxykynuramine, a brain metabolite of melatonin.
    León J; Escames G; Rodríguez MI; López LC; Tapias V; Entrena A; Camacho E; Carrión MD; Gallo MA; Espinosa A; Tan DX; Reiter RJ; Acuña-Castroviejo D
    J Neurochem; 2006 Sep; 98(6):2023-33. PubMed ID: 16945113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Indomethacin and aspirin inhibition of prostaglandin E2 synthesis by sheep seminal vesicles microsome powder.
    Raz A; Stern H; Kenig-Wakshal R
    Prostaglandins; 1973 Mar; 3(3):337-52. PubMed ID: 4729577
    [No Abstract]   [Full Text] [Related]  

  • 6. Structure-activity studies of melatonin analogues in prepubertal male rats.
    Kennaway DJ; Hugel HM; Clarke S; Tjandra A; Johnson DW; Royles P; Webb HA; Carbone F
    Aust J Biol Sci; 1988; 41(3):393-400. PubMed ID: 3270504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of prostaglandin synthase by pirprofen. Studies with sheep seminal vesicle enzyme.
    Ku EC; Wasvary JM
    Biochim Biophys Acta; 1975 Apr; 384(2):360-8. PubMed ID: 804924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PGHS-2 inhibitors, NS-398 and DuP-697, attenuate the inhibition of PGHS-1 by aspirin and indomethacin without altering its activity.
    Rosenstock M; Danon A; Rimon G
    Biochim Biophys Acta; 1999 Aug; 1440(1):127-37. PubMed ID: 10477832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of N1-acetyl-N2-formyl-5-methoxykynuramine/N1-acetyl-5-methoxy-kynuramine formation from melatonin in mice.
    Niu S; Li F; Tan DX; Zhang L; Idle JR; Gonzalez FJ; Ma X
    J Pineal Res; 2010 Sep; 49(2):106-14. PubMed ID: 20545825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of substrate concentration on inhibition of prostaglandin synthetase of bull seminal vesicles by anti-inflammatory drugs and fenamic acid analogs.
    Cushman DW; Cheung HS
    Biochim Biophys Acta; 1976 Mar; 424(3):449-59. PubMed ID: 816374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The melatonin metabolite N-acetyl-5-methoxykynuramine is a potent singlet oxygen scavenger.
    Schaefer M; Hardeland R
    J Pineal Res; 2009 Jan; 46(1):49-52. PubMed ID: 18643875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative effects of aspirin and diflunisal on prostaglandin synthetase from human platelets and sheep seminal vesicles.
    Majerus PW; Stanford N
    Br J Clin Pharmacol; 1977 Feb; 4 Suppl 1(Suppl 1):15S-18S. PubMed ID: 406909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutrophils as a specific target for melatonin and kynuramines: effects on cytokine release.
    Silva SO; Rodrigues MR; Ximenes VF; Bueno-da-Silva AE; Amarante-Mendes GP; Campa A
    J Neuroimmunol; 2004 Nov; 156(1-2):146-52. PubMed ID: 15465605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reactions of the melatonin metabolite AMK (N1-acetyl-5-methoxykynuramine) with reactive nitrogen species: formation of novel compounds, 3-acetamidomethyl-6-methoxycinnolinone and 3-nitro-AMK.
    Guenther AL; Schmidt SI; Laatsch H; Fotso S; Ness H; Ressmeyer AR; Poeggeler B; Hardeland R
    J Pineal Res; 2005 Oct; 39(3):251-60. PubMed ID: 16150105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of endogenous and exogenous N-acetyl-5-methoxy kynuramine on object recognition memory in male C3H mice.
    Iwashita H; Sano M; Chiba A
    Horm Behav; 2023 Apr; 150():105329. PubMed ID: 36841054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel enzyme-dependent melatonin metabolite in humans.
    Li C; Li G; Tan DX; Li F; Ma X
    J Pineal Res; 2013 Jan; 54(1):100-6. PubMed ID: 24446865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxidation of melatonin by singlet molecular oxygen (O2(1deltag)) produces N1-acetyl-N2-formyl-5-methoxykynurenine.
    de Almeida EA; Martinez GR; Klitzke CF; de Medeiros MH; Di Mascio P
    J Pineal Res; 2003 Sep; 35(2):131-7. PubMed ID: 12887657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N1-acetyl-N2-formyl-5-methoxykynuramine is a product of melatonin oxidation in rats.
    Rozov SV; Filatova EV; Orlov AA; Volkova AV; Zhloba AR; Blashko EL; Pozdeyev NV
    J Pineal Res; 2003 Nov; 35(4):245-50. PubMed ID: 14521629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flurbiprofen: highly potent inhibitor of prostaglandin synthesis.
    Nozu K
    Biochim Biophys Acta; 1978 Jun; 529(3):493-6. PubMed ID: 96864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of 5-hydroxykynurenamine, L-kynurenine and kynuramine with multiple serotonin receptors in smooth muscle.
    Pomfret DW; Schenck KW; Fludzinski P; Cohen ML
    J Pharmacol Exp Ther; 1987 May; 241(2):465-71. PubMed ID: 3572806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.